ATAD2 and metastatic malignant neoplasm in the lymph nodes: ATAD2 overexpression is closely associated with positive LUAD lymph node metastasis, poor tumor differentiation, advanced disease stage, and prognosis, and it is an individual marker of adverse prognosis after surgical resection of lung adenocarcinoma [5,47,126,127].